Valuation check: LQDA's profit margin is 22.18%, above the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Liquidia (LQDA) currently reports a profit margin of 22.18% as of March 2026. That compares with -740.09% in the prior-year period — up 103.0% year over year. That is above the Healthcare sector average of 14.34%. Use the charts on this page to explore Liquidia's profit margin history and peer comparisons.
Liquidia's profit margin increased from -740.09% to 22.18% — a 103.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Liquidia's profit margin of 22.18% is higher than the Healthcare sector average of 14.34%. That is roughly 54.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Liquidia's current 22.18% should be judged against Healthcare norms (sector average: 14.34%) and against LQDA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 22.18%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Liquidia, and consider following LQDA for alerts when major investors trade the stock.